 |
AEZS-108 (LHRH-agonist linked to doxorubicin) |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2010-04-30 00:00:00 |
| Sponsor | Aeterna Zentaris;100 Marketplace, Suite 203, 25 Mountainview Blvd;Basking Ridge, New Jersey, 07920 |
